Sep 2, 2025, 08:47
SUGAR Trial in Heart BMJ: Stent Outcomes in Patients With Diabetes Under the Spotlight
Heart BMJ posted on X:
”SUGAR and stents: evaluating long-term percutaneous coronary intervention outcomes in patients with diabetes”
Read the full articlle here.
Diabetes makes coronary disease more severe, with narrower, calcified vessels.
Patients with diabetes face higher risks after PCI — heart attack, stent problems, repeat procedures, death.
Risks exist even in silent or pre-diabetes.
Drug-eluting stents improved outcomes but risk stays higher vs. non-diabetics.
The SUGAR trial tested new stents in diabetes — no clear winner yet, but key insights for care.
Stay updated with Haemostasis Today.
-
Nov 16, 2025, 19:46Ayodeji Olayanju: Academics Blood Matter Too!
-
Nov 16, 2025, 19:30Thomas Reiser Congratulates Saskia Middeldorp on Delivering the 2025 Sol Sherry Distinguished Lecture in Thrombosis
-
Nov 15, 2025, 15:47Shannon Farmer: Congratulations to Susan Goobie and Colleagues on Publication of Their Important Study
-
Nov 15, 2025, 15:46Fotios Barkas: Explore the Latest Articles From the Journal of Atherosclerosis Prevention and Treatment!
-
Nov 15, 2025, 15:45Ludovic Helfgott: Researchers Have Analysed Novo Nordisk Product Data in Obesity and Cardiovascular Disease
-
Nov 15, 2025, 15:42Haroun Gajraj Thanks Enric Roche for Demonstrating the Piston Effect
-
Nov 15, 2025, 15:41Thrombectomy Rates Rise 700% Nationwide
-
Nov 15, 2025, 15:41Emmanuel J. Favaloro: Transitioning Patients from DOACs to Heparin
-
Nov 15, 2025, 15:40Bruno Lima: I Owe a Lot of My Career to Dr. Brad Maron